CF
Cantor Fitzgerald Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
451
Immunome
IMNM
$916M
|
PS
Pete Stavropoulos
| $10.52 | $8 |
24%
downside
| Overweight |
20 Mar ‘23
2 years ago |
|
452
Galecto
GLTO
$3.99M
|
KK
Kristen Kluska
| $3.01 | $400 |
13,189%
upside
| Overweight |
17 Mar ‘23
2 years ago |
|
453
Village Farms International
VFF
$301M
|
PZ
Pablo Zuanic
| $2.67 | $4.15 |
55%
upside
| Overweight |
10 Mar ‘23
2 years ago |
|
|
LENZ
454
LENZ Therapeutics
LENZ
$1.2B
|
OB
Olivia Brayer
| $41.98 | $21 |
50%
downside
| Neutral |
23 Feb ‘23
2 years ago |
|
|
CGC
455
Canopy Growth
CGC
$456M
|
PZ
Pablo Zuanic
| $1.46 | $32 |
2,092%
upside
| Neutral |
17 Feb ‘23
2 years ago |
|
456
Digi International
DGII
$1.29B
|
DS
Derek Soderberg
| $34.69 | $48 |
38%
upside
| Overweight |
3 Feb ‘23
2 years ago |
|
|
LIEN
457
Chicago Atlantic BDC, Inc. Common Stock
LIEN
$246M
|
PZ
Pablo Zuanic
| $10.77 | $15.30 |
42%
upside
| Overweight |
6 Jan ‘23
2 years ago |
|
458
Anavex Life Sciences
AVXL
$807M
|
CD
Charles Duncan
| $9.40 | $11 |
17%
upside
| Neutral |
6 Dec ‘22
2 years ago |
|
459
Veru
VERU
$49.4M
|
BF
Brandon Folkes
| $3.37 | $220 |
6,428%
upside
| Overweight |
5 Dec ‘22
2 years ago |
|
460
Sundial Growers
SNDL
$638M
|
PZ
Pablo Zuanic
| $2.48 | $3.60 |
45%
upside
| Neutral |
28 Nov ‘22
2 years ago |
|
461
Fennec Pharmaceuticals
FENC
$250M
|
CD
Charles Duncan
| $9 | $12 |
33%
upside
| Overweight |
22 Nov ‘22
2 years ago |
|
462
Zevra Therapeutics
ZVRA
$502M
|
LC
Louis Chen
| $8.95 | $20 |
123%
upside
| Overweight |
17 Nov ‘22
2 years ago |
|
463
WM Technology
MAPS
$126M
|
PZ
Pablo Zuanic
| $1.17 | $5 |
327%
upside
| Overweight |
8 Nov ‘22
2 years ago |
|
|
CISO
464
CISO Global
CISO
$34.7M
|
JR
Jonathan Ruykhaver
| $1.04 | $75 |
7,112%
upside
| Overweight |
21 Oct ‘22
2 years ago |
|
465
Tilray
TLRY
$1.31B
|
PZ
Pablo Zuanic
| $1.19 | $4.50 |
278%
upside
| Neutral |
10 Oct ‘22
2 years ago |
|
466
iBio
IBIO
$16.4M
|
KK
Kristen Kluska
| $0.8350 | $85 |
10,080%
upside
| Neutral |
7 Oct ‘22
2 years ago |
|
|
MSPR
467
MSP Recovery, Inc. Class A Common Stock
MSPR
$2.38M
|
JS
Josh Siegler
| $2.55 | $21 |
724%
upside
| Overweight |
29 Sep ‘22
2 years ago |
|
|
468
Digi International
DGII
$1.29B
|
JR
Jonathan Ruykhaver
| $34.69 | $41 |
18%
upside
| Overweight |
8 Sep ‘22
3 years ago |
|
469
Nkarta
NKTX
$161M
|
LW
Li Watsek
| $2.26 | $38 |
1,581%
upside
| Overweight |
12 Aug ‘22
3 years ago |
|
470
Flora Growth
FLGC
$13M
|
PZ
Pablo Zuanic
| $22.50 | $663 |
2,847%
upside
| Neutral |
1 Aug ‘22
3 years ago |
|
471
Pliant Therapeutics
PLRX
$114M
|
PS
Pete Stravropoulos
| $1.86 | $40 |
2,051%
upside
| Overweight |
26 Jul ‘22
3 years ago |
|
472
Arcturus Therapeutics
ARCT
$485M
|
PS
Pete Stravropoulos
| $17.85 | $39 |
118%
upside
| Overweight |
19 Jul ‘22
3 years ago |
|
473
Alaunos Therapeutics
TCRT
$4.27M
|
PA
Prakhar Agrawal
| $2.16 | $450 |
20,733%
upside
| Overweight |
15 Jul ‘22
3 years ago |
|
|
HITI
474
High Tide
HITI
$300M
|
PZ
Pablo Zuanic
| $3.44 | $4.45 |
29%
upside
| Neutral |
16 Jun ‘22
3 years ago |
|
475
Novavax
NVAX
$1.28B
|
CD
Charles Duncan
| $7.90 | $168 |
2,027%
upside
| Overweight |
8 Jun ‘22
3 years ago |
|